Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Chronic Heart Failure Patients
IRCT20230331057788N1Phase 4Completed
- Sponsor
- National University of Medical Sciences
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dapagliflozin in chronic heart failure (CHF), sponsored by National University of Medical Sciences. Started Apr 2023; status: completed.
02
Drugs
dapagliflozin
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on IRCT20230331057788N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230331057788N1.